London, 5 August 2026 – Endocrinologist Saira Hameed’s Signals: The Inside Story of Our Hormones examines the powerful role hormones play in health, fertility, mood and behaviour while making a case for patient-centred medicine at a time when artificial intelligence is entering the consulting room.
Published by Faber, the 336-page book combines medical explanation, professional memoir and clinical storytelling. Rather than presenting endocrinology as an abstract scientific discipline, Hameed describes how disturbances in the body’s chemical signalling systems can alter everyday life and leave patients struggling with symptoms that are difficult to identify.
The stories span infertility, obesity, diabetes and longstanding conditions that have resisted straightforward diagnosis. Across these cases, the physician’s task is presented as a form of investigation requiring scientific knowledge, attention to small physical clues and a detailed understanding of the patient’s personal history.
This emphasis on listening gives the book particular relevance as healthcare systems invest more heavily in automation. AI can organise information, identify patterns and support clinical decisions, but Hameed argues that endocrinology remains rooted in the interaction between a patient explaining an experience and a clinician interpreting it.
That distinction matters commercially as technology companies pursue opportunities in diagnostics, digital health and clinical workflow. Products capable of helping doctors process complex information may create genuine value, but tools designed without regard for patient context risk overlooking the ambiguity that frequently accompanies hormonal and metabolic disorders.
The book also explores the limits of medicine. Treatment can transform lives when the cause of an illness is identified and corrected, yet test results do not always align neatly with how a patient feels. Hameed’s account resists the assumption that every case will produce a redemptive outcome, offering a more realistic view of healthcare delivery and patient expectations.
Her professional journey provides another narrative thread. Early uncertainty gradually gives way to confidence as clinical experience develops, but the book avoids portraying expertise as infallibility. Curiosity, empathy and a willingness to hear the patient’s full story remain as important as technical knowledge.
A section reflecting on the Covid-19 pandemic broadens the discussion beyond endocrinology. Hameed recounts the strain placed on medical professionals during a period when treatments were limited and clinical teams confronted uncertainty on an exceptional scale.
For Asian healthcare investors, the themes intersect with several long-term areas of demand. Ageing populations, diabetes, obesity, reproductive health and other chronic conditions are increasing the need for specialist care, earlier diagnosis and sustained patient management across the region.
These trends create opportunities for hospitals, diagnostic laboratories, pharmaceutical companies and health-technology platforms. However, the book’s central message suggests that successful healthcare models must combine scale and technological efficiency with continuity of care and human judgement.
The Ledger Asia Insights
Signals provides a useful counterweight to investment narratives that treat AI as a direct replacement for medical professionals. The more credible commercial opportunity may lie in technology that strengthens a clinician’s capabilities, reduces administrative work and highlights relevant patterns without removing accountability from the treatment process.
The book also illustrates why endocrine and metabolic care can generate recurring demand. Many conditions require continuing monitoring, medication and behavioural support rather than a single intervention. This favours healthcare providers with integrated diagnostics, specialist expertise and effective long-term patient engagement.
Investors evaluating Asia’s expanding health-technology market should therefore look beyond algorithmic capability alone. Data quality, clinical validation, regulatory compliance and acceptance by doctors and patients will determine whether innovation produces sustainable value. Hameed’s account reinforces a durable principle for the sector: technology can improve the reach and precision of medicine, but trust, careful interpretation and humane care remain fundamental to outcomes and commercial credibility.
